Do any of the following medications—vortioxetine (Trintellix) 10 mg daily, omeprazole 40 mg delayed‑release daily, desvenlafaxine succinate extended‑release 50 mg daily, or rosuvastatin calcium 10 mg daily—interfere with the measurement of a morning serum cortisol level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Medication Effects on Morning Cortisol Testing

None of these four medications—vortioxetine (Trintellix), omeprazole, desvenlafaxine, or rosuvastatin—are known to directly interfere with morning serum cortisol measurement, and you can proceed with testing without holding them.

Key Considerations for Cortisol Testing

The most recent joint guideline from the European Society of Endocrinology and Endocrine Society (2024) addresses factors that affect morning cortisol interpretation but does not list any of your patient's medications as interfering substances 1.

Factors That Actually Affect Cortisol Measurement

According to the 2024 guidelines, the following conditions genuinely alter cortisol concentrations 1:

Falsely elevated cortisol:

  • Pregnancy
  • Oral estrogen use (increases cortisol-binding globulin)

Falsely decreased cortisol:

  • Hypoalbuminemic states (cirrhosis, nephrotic syndrome, malnutrition)
  • Prolonged critical illness
  • Disrupted circadian rhythm (night shift work, jet lag, severe insomnia)

Assay-Related Interference

The 2016 Endocrine Society guideline emphasizes that liquid chromatography-tandem mass spectrometry (LC-MS/MS) is relatively free from analytical interferences associated with medications and dietary constituents, unlike older immunoassays 2. If your laboratory uses LC-MS/MS, medication interference is even less of a concern.

The 2024 guideline confirms that immunoassays can show variability between different methods, with baseline cortisol cutoffs varying between 336-506 nmol/L (12.2-18.3 μg/dL) depending on the assay used 1. However, this reflects assay methodology differences, not medication interference.

Specific Medication Review

Vortioxetine (Trintellix): Research shows it affects the HPA axis by enhancing glucocorticoid receptor translocation and improving stress responsiveness 3, but this represents a physiological effect on cortisol production, not analytical interference with the assay. The FDA label contains no warnings about cortisol testing interference 4.

Omeprazole: No evidence suggests interference with cortisol assays. While it has numerous drug interactions via CYP450 pathways 5, cortisol measurement is not affected.

Desvenlafaxine: No documented interference with cortisol testing. Clinical trials comparing it to vortioxetine made no mention of cortisol assay concerns 6, 7.

Rosuvastatin: The FDA label describes its pharmacokinetics in detail but mentions no interference with steroid hormone measurements 8.

Clinical Bottom Line

Proceed with morning cortisol testing without medication adjustments. Ensure the blood draw occurs in the early morning (ideally 8-9 AM) when cortisol peaks naturally, and verify that the patient has maintained normal sleep-wake cycles. If your laboratory uses immunoassays rather than LC-MS/MS, be aware that the specific assay cutoffs may vary, but none of these medications are known to cause cross-reactivity or analytical interference 2, 1.

References

Related Questions

Which is a better antidepressant to switch to for a patient on desvenlafaxine (Pristiq): vortioxetine (Trintellix) or vilazodone (Viibryd)?
Is it safe and appropriate to combine vortioxetine with desvenlafaxine for augmentation in a patient with major depressive disorder?
In an 84-year-old woman with normal laboratory values and a solitary kidney who has intermittent gastroesophageal reflux disease, is a daily dose of omeprazole 20 mg or an as‑needed dose of omeprazole 40 mg more appropriate?
What antidepressants are pharmacologically similar to desvenlafaxine (Pristiq)?
What is the recommended management after an initial omeprazole drip in a patient presenting with melena?
Which microorganisms are associated with lichen planus and what screening tests should be performed for them?
While on low-dose cefalexin (Keflex), what laboratory tests and imaging studies should be monitored?
In a patient with hypertension and impaired renal function (serum creatinine 2.4 mg/dL) and leukocytosis (WBC 26,000), which antibiotic—cefepime or linezolid—is safer to use?
How should a patient with hypercholesterolemia and a lipid panel showing total cholesterol 280 mg/dL, LDL (low-density lipoprotein) 143 mg/dL, HDL (high-density lipoprotein) 117 mg/dL, and triglycerides 100 mg/dL be managed?
Does severe malaria include severe thrombocytopenia, and should a patient with a platelet count of 18 × 10⁹/L be admitted to the intensive care unit?
What physiologic pulmonary changes occur during pregnancy and what are the clinical implications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.